Abstract:The diagnosis of multiple sclerosis (MS) is challenging for the lack of a specific diagnostic test. Recent researches in quantitative proteomics, however, offer new opportunities for biomarker discovery and the study of disease pathogenesis. To find more potential protein biomarkers, we used two technologies, 2-dimensional fluorescence difference in-gel electrophoresis (2D-DIGE), followed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and ultra-performance liquid chromato-graph coupled with quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS), to quantitatively analyse differential proteomic expression in the cerebrospinal fluid (CSF) between patients with MS (the experiment group) and patients with other neurological diseases (ONDs; the control group). Analysis by the former technology identified more than 43 different protein spots (39 proteins), of which 17 spots (13 proteins) showed more than 1.5-fold difference in abundance as analysed by DeCyder software (GE Healthcare, Piscataway. NJ, USA) between the MS and the ONDs groups. The expression of five protein spots was elevated and the expression of 12 protein spots was decreased in the MS group. Meanwhile, the latter method, UPLC/Q-TOF MS showed 68 different proteins. There were 45 proteins with a difference of more than 1.5 folds between the two groups, in which the expression of 20 proteins was elevated and the expression of 25 proteins was decreased in the MS group. Data provided by the two methods indicated that the proteins overlapped ratio was 27% in the 26 significant proteins that had the same regulation tendency. The differential CSF proteins were analysed further by biological network and it revealed interaction of them. The subsequent ELISA measuring the concentration of cystatin C (P < 0.01), which was one of the proteins discovered simultaneously with the two technologies, confirmed the results of the two quantitative proteomic analysis. The combination of the two quantitative proteomic technologies was helpful in discovering differentially expressed proteins that may have a connection with MS disease physiology and serve as useful biomarkers for diagnosis and treatment of MS diseases.

Identification of Discrepant Proteins Between Normal Ependyma and Ependymoma of Spinal Cord by Using Proteomics Technology

Study on Proteomic Profile of Normal Ependyma and Ependymoma of Spinal Cord by Using Three-Diamensional Shot-gun and MS/MS Technology

Global Protein Differential Expression Profiling of Cerebrospinal Fluid Samples Pooled from Chinese Sporadic CJD and non-CJD Patients

Protemics Investigation of Cerebrospinal Fluid of Ependymoma

Differential Proteome Profiling of Pleural Effusions from Lung Cancer and Benign Inflammatory Disease Patients

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Two dimensional electrophoresis analysis and mass spectrometry identification of proteins in transected rat spinal cord

Establishment of two-dimensional differential gel electrophoresis using cerebrospinal fluid from patients with medulloblas-toma and patients with ependymoma

Research on Glioma Protein Profile and Screening of Its Disease-related Proteins in Tissues

Comparative Study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's Disease

Identification of differential expressed proteins between high and low differentiation colorectal carcinoma tissues by two-dimensional electrophoresis and MALDI-TOF mass spectrometry

Identification of Tumor-related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors

Comparative Proteomic Profiles of the Normal and Aganglionic Hindgut in Human Hirschsprung Disease.

Establishment of a two-dimensional electrophoresis technologic platform on neuroproteomics

Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis

Quantitative Proteomic Analysis of the Cerebrospinal Fluid of Patients with Multiple Sclerosis

Identification Of Predictive Proteins And Biological Pathways For The Tumorigenicity Of Vestibular Schwannoma By Proteomic Profiling

Differential Protein Expression Between Cystic and Solid Vestibular Schwannoma Using Tandem Mass Tag‐Based Quantitative Proteomic Analysis

Proteome Research of Acute Spinal Injury by Two-Dimensional Gel Electrophoresis Analysis and Mass Spectrometry Identification

Pediatric Ependymoma: A Proteomics Perspective

Comparative Proteomics Analysis of Human Gastric Cancer